Characteristics of trials in PACTR
| Description | N (%) |
| Number of trials registered | 2998 |
| Number of studies completed | 1083 (36.1) |
| Number of completed with results | 94 (3.1) |
| Overall trial status | |
| Completed | 1083 (36.1) |
| Recruiting | 755 (25.2) |
| Not yet recruiting/pending | 836 (27.9) |
| Recruiting | 755 (25.2) |
| Stopped/terminated | – |
| Suspended | 7 (0.2) |
| Pending | 836 (27.5) |
| Other/unknown | 317 (10.6) |
| Prospective/retrospective | |
| Prospectively registered | 1655 (55.2) |
| Retrospectively registered | 1343 (44.8) |
| Intervention model | |
| Parallel assignment | 2124 (70.8) |
| Single group assignment | 59 (2.0) |
| Cross-over assignment | 201 (6.7) |
| Factorial assignment | 589 (19.6) |
| Sequential assignment | 13 (0.4) |
| None (open label) | 12 (0.4) |
| Phase | |
| Not reported | 2310 (77.1) |
| Phase I | 192 (6.5) |
| Phase II | 138 (4.6) |
| Phase III | 199 (6.6) |
| Phase IV | 155 (5.2) |
| Primary sponsor | |
| University | 196 (6.5) |
| Industry or non-governmental organisation | 61 (2.0) |
| Government | 107 (3.6) |
| Charities | 94 (3.1) |
| Hospital | 67 (2.2) |
| Self-funded | 693 (23.1) |
| Funding agency | 142 (4.7) |
| Other | 45 (1.5) |
| No funding | 1639 (54.7) |
| Ethics approval received | |
| Yes | 2691 (90) |
| No | 307 (10) |
| Sex | |
| Both male and female | 2240 (74.7) |
| Female | 628 (20.9) |
| Male | 130 (4.3) |
| The target number of participants | |
| Minimum, maximum | 0–1 087 000 |
| Mean (SD) | 1–140.7 (26–156.8) |
| Median (IQR) | 80 (1–125) |
PACTR, Pan African Clinical Trials Registry.